AAMU
TMO icon

AEGON Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History

AEGON Asset Management (UK)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,972
Closed -$34.2M – 184
2025
Q4 		$34.2M Sell
58,972
-1,644
-3% -$930K 0.41% 68
2025
Q3 		$29.4M Buy
60,616
+13,857
+30% +$6.45M 0.35% 72
2025
Q2 		$19M Sell
46,759
-85
-0.2% -$35.5K 0.24% 95
2025
Q1 		$23.3M Sell
46,844
-2,621
-5% -$1.42M 0.34% 76
2024
Q4 		$25.7M Sell
49,465
-7,919
-14% -$4.35M 0.34% 73
2024
Q3 		$35.5M Buy
57,384
+507
+0.9% +$300K 0.48% 51
2024
Q2 		$31.4M Buy
56,877
+50,775
+832% +$29.1M 0.44% 57
2024
Q1 		$3.54M Sell
6,102
-602
-9% -$338K 0.05% 108
2023
Q4 		$3.56M Buy
+6,704
New +$3.24M 0.06% 106
2023
Q2 		$3.72M Sell
7,129
-662
-8% -$357K 0.06% 113
2023
Q1 		$4.49M Hold
7,791
– – 0.08% 110
2022
Q4 		$4.29M Buy
7,791
+1,669
+27% +$884K 0.08% 111
2022
Q3 		$3.11M Sell
6,122
-380
-6% -$213K 0.06% 110
2022
Q2 		$3.54M Buy
6,502
+534
+9% +$294K 0.07% 112
2022
Q1 		$3.53M Sell
5,968
-1,466
-20% -$842K 0.05% 119
2021
Q4 		$4.96M Buy
7,434
+165
+2% +$103K 0.06% 126
2021
Q3 		$4.15M Sell
7,269
-922
-11% -$506K 0.06% 126
2021
Q2 		$4.13M Hold
8,191
– – 0.06% 129
2021
Q1 		$3.74M Sell
8,191
-343
-4% -$164K 0.06% 125
2020
Q4 		$3.97M Hold
8,534
– – 0.06% 116
2020
Q3 		$3.76M Buy
8,534
+584
+7% +$241K 0.08% 96
2020
Q2 		$2.88M Buy
7,950
+1,177
+17% +$395K 0.06% 102
2020
Q1 		$1.92M Hold
6,773
– – 0.06% 114
2019
Q4 		$2.2M Buy
6,773
+2,656
+65% +$805K 0.05% 129
2019
Q3 		$1.2M Hold
4,117
– – 0.03% 152
2019
Q2 		$1.21M Hold
4,117
– – 0.03% 156
2019
Q1 		$1.13M Buy
+4,117
New +$1.02M 0.03% 151
2017
Q1 		– Sell
-4,107
Closed -$580K – 250
2016
Q4 		$580K Sell
4,107
-217
-5% -$32K 0.02% 207
2016
Q3 		$688K Buy
+4,324
New +$666K 0.02% 191

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AEGON Asset Management (UK)'s TMO Position: Q1 2026 in Review

AEGON Asset Management (UK) sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 58,972 shares — an estimated $34.2M sold.

AEGON Asset Management (UK) first reported a position in TMO in Q3 2016 and held it in 29 quarters. The position peaked at $35.5M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AEGON Asset Management (UK) reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 58,972 Thermo Fisher Scientific shares in Q1 2026, an estimated $34.2M.
  • AEGON Asset Management (UK) first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 29 quarters.
  • AEGON Asset Management (UK)'s Thermo Fisher Scientific position peaked at $35.5M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q1 2026, filed 16 Apr 2026.